Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MNK155 vs Norco for Post-Operative Pain
NCT02381132Phase 3Terminated
- Start
- Nov 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of MNK-155 in postoperative pain (2 arms). Primary endpoint: Post-operative Pain Control at 48 hours. Started Nov 2014; status: terminated.
02
Drugs
MNK-155
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02381132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02381132.